Literature DB >> 29353684

Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?

Andrea De Giglio1, Roberta Porreca2, Marta Brambilla2, Giulio Metro2, Enrico Prosperi3, Guido Bellezza3, Matteo Pirro4, Rita Chiari2, Biagio Ricciuti2.   

Abstract

Entities:  

Keywords:  ALK; DIC; NSCLC; Thrombosis

Mesh：

Year:  2017        PMID： 29353684     DOI： 10.1016/j.thromres.2017.12.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

Review 1.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Blood Adv       Date:  2019-11-26

2.  Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Authors:  Hanny Al-Samkari; Jean M Connors
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells.

Authors:  Akihiko Miyanaga; Masaru Matsumoto; Jessica A Beck; Izumi Horikawa; Takahiro Oike; Hirokazu Okayama; Hiromi Tanaka; Sandra S Burkett; Ana I Robles; Mohammed Khan; Delphine Lissa; Masahiro Seike; Akihiko Gemma; Hiroyuki Mano; Curtis C Harris
Journal:  BMC Cancer       Date:  2021-03-24       Impact factor: 4.430

Review 4.  Disseminated intravascular coagulation complicating diagnosis of ROS1-mutant non-small cell lung cancer: A case report and literature review.

Authors:  Rachel Woodford; Michel Lu; Nadine Beydoun; Wendy Cooper; Qin Liu; Jodi Lynch; Lawrence Kasherman
Journal:  Thorac Cancer       Date:  2021-07-22       Impact factor: 3.500
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.